Study in Healthy Tubal Ligated Women to Evaluate Pharmacodynamics, Safety and Pharmacokinetics of BAY1002670
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
Effects of BAY1002670 on bleeding pattern: non-bleeding rate; on endometrium; on ovarian
function; return of menstrual bleeding after treatment; safety and tolerability; PK/PD
(pharmacokinetic/pharmacodynamic) relationship